Resources

Try these: RegTechComplianceFDARegulatory Intelligence

Try these: RegTechCompliance

Filter Resources
US Congress Confirms Martin Makary as FDA Commissioner …
On March 25, 2025, the U.S. Senate confirmed Dr. Marty Makary to lead the Food and Drug Administration (FDA) and Dr. Jay Bhattacharya to hea…
Read more
COFEPRIS (Mexico) Publishes Guidelines for GMP Document…
On March 20, 2025, the Mexican Federal Commission for Protection against Health Risks (COFEPRIS) published in the Official Gazette (DOF) the…
Read more
West Virginia Governor Signs Legislation Prohibiting Ce…
The Governor of West Virginia has signed House Bill 2354 into law, amending §16-7-2 of the Code of West Virginia, 1931. This new legislatio…
Read more
CDE (China) Publishes Guideline for Biologics Registrat…
On February 9, 2025, the Center for Drug Evaluation (CDE) announced the release of the “Guideline for Acceptance Review of Biological …
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
DINAVISA (Paraguay) Approves New Guideline for Good Eva…
On December 2, 2024, the National Directorate of Sanitary Surveillance (DINAVISA) introduced the “Guide to Good Evaluation Practices f…
Read more
AGEMED (Bolivia) Opens Public Consultation on Draft Gui…
The Bolivian Agency for Medicines and Health Technologies (AGEMED) announced on November 25, 2024, the launch of a public consultation on it…
Read more